Tela Bio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $19,291 | $19,059 | $20,869 | $20,689 |
Gross Profit | 13,943 | 12,520 | 13,755 | 13,969 |
EBITDA | -9,031 | -9,896 | -7,034 | -7,154 |
EBIT | -9,126 | -10,160 | -7,259 | -7,402 |
Net Income | -11,262 | -12,273 | -9,041 | -8,603 |
Net Change In Cash | 19,291 | 19,059 | 20,869 | 20,689 |
Free Cash Flow | -9,440 | -11,289 | -4,961 | -5,930 |
Cash | 30,424 | 39,541 | 50,845 | 29,713 |
Basic Shares | 57,414 | 57,256 | 51,683 | 45,421 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $80,275 | $69,300 | $58,453 | $41,418 |
Gross Profit | 54,341 | 46,488 | 40,112 | 27,044 |
EBITDA | -32,346 | -31,683 | -40,633 | -39,058 |
EBIT | -33,356 | -32,695 | -41,441 | -40,245 |
Net Income | -38,831 | -37,841 | -46,664 | -44,296 |
Net Change In Cash | 80,275 | 69,300 | 58,453 | 41,418 |
Cost of Revenue | -1,768 | |||
Free Cash Flow | -28,667 | -42,584 | -41,468 | -42,620 |
Cash | 50,845 | 52,670 | 46,729 | 42,019 |
Basic Shares | 46,947 | 28,526 | 22,868 | 16,267 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.20 |
2026-03-31 | -$0.21 |
2025-12-31 | -$0.17 |
2025-09-30 | -$0.19 |